Future work will be necessary to understand whether Tsc1 deletion induced shifts in CIN cell programming underlie behavioral abnormalities in mutant mice and humans diagnosed with TSC, which may lead to new therapeutic targets. Here, TSC1 is linked to tuberous sclerosis.